Skip to main content
SpringerLink
Log in

Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

The binding of 3H-paroxetine and 3H-imipramine has been compared in 17 different regions of 12 human control brains. Our findings reveal that the regional distribution is similar for both radioligands and their bindings tend to be parallel in the brain. The highest binding site density was found in basal ganglia (hypothalamus Bmax 780 ± 102 fmol/mg protein for 3H-imipramine binding and Bmax 515∼ 83 for 3H-paroxetine binding). The lowest values were found in cortical areas (cingulate cortex 191 ± 18.5 fmol/mg for 3H-imipramine binding and 88 ± 7.5 fmol/mg for 3H-paroxetine binding). The Kd values for 3H-paroxetine binding to neuronal membranes were similar in all brain regions (mean ± s.d. Kd 0.07 ± 0.007 nM) and also for 3H-imipramine binding (mean ± s.d. Kd 1.05 ± 0.12 nM). As these values are the same as in platelet membrane, the results obtained indicate that both binding sites are identical in neuronal and in platelet membranes.

These findings suggest that both ligands are good markers of the 5HT transporter. However, the higher affinity of 3H-paroxetine confirms that this compound is a better radioligand for the 5HT uptake site.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arranz B, Marcusson J (1994) 3H-Paroxetine and 3H-citalopram as markers of the human brain 5-HT uptake site: a comparison study. J Neural Transm 97: 27–40

    Google Scholar 

  • Asarch KB, Shin JC, Kuleasar A (1988) Decreased 3H-imipramine binding in depressed males and females. Commun Psychopharmacol 4: 425–432

    Google Scholar 

  • Backstrom IT, Marcusson JO (1987) 5 Hydroxytryptamine-sensitive 3H imipramine binding of protein nature in the human brain. I. Characteristics. Brain Res 425: 128–136

    Google Scholar 

  • Backstrom IT, Bergstrom M, Marcusson J (1989) High affinity 3H paroxetine binding to serotonine uptake sites in human brain tissue. Brain Res 486: 261–268

    PubMed  Google Scholar 

  • Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E (1980) Tritiated 3H-imipramine binding sites are decreased in platelet of untreated depressed patients. Science 209: 303–305

    PubMed  Google Scholar 

  • Bucht G, Adolfsson R, Gottfries CG, Ross BE, Winblad B (1981) Distribution of 5-hydroxytryptamine and 5-hydroxyindolic acid in human brain in relation to age, drug influence, agonal status and circadian variation. J Neural Transm 51: 185–203

    PubMed  Google Scholar 

  • Dewar KM, Reader TA, Grondin L, Descarries L (1991) 3H-paroxetine binding and serotonin content of rat and rabbit cortical areas, hyppocampus, neostriatum, ventral mesencephalic tegmentum and midbrain raphe nuclei region. Synapse 9: 14–18

    PubMed  Google Scholar 

  • Gobbi M, Taddei C, Mennini T (1997) Different components of 3H-imipramine binding in rat brain membranes: relation to serotonin uptake sites. Life Sci 42: 575–583

    Google Scholar 

  • Habert E, Graham D, Tahraoui L, Claustre Y, Langer SZ (1985) Characterization of 3H-paroxetine binding to rat cortical membranes. Eur J Pharmacol 118: 107–114

    PubMed  Google Scholar 

  • Hrdina PD (1984) Differentiation of two components of specific 3H imipramine binding in rat brain. Eur J Pharmacol 102: 481–488

    PubMed  Google Scholar 

  • Hrdina PD (1987) Sodium dependent 3H-imipramine binding in rat hippocampus and its relationship to serotonin uptake. Can J Physiol Pharmacol 65: 2422–2427

    PubMed  Google Scholar 

  • Hrdina PD (1988) Inhibition of sodium dependent 3H-imipramine binding in rat brain by serotonin and serotonin uptake inhibitors. Eur J Pharmacol 147: 279–282

    PubMed  Google Scholar 

  • Hrdina PD (1989) Differences between sodium dependent and desipramine defined 3H-imipramine binding in intact human platelets. Biol Psychiatry 576–584

  • Hrdina PD, Foy B, Hepher A, Summer RJ (1990a) Antidepressant binding sites in brain: autoradiographic comparison of 3H-paroxetine and 3H-imipramine localization and relation to serotonine transporter. J Pharmacol Exp Ther 252: 410–418

    PubMed  Google Scholar 

  • Hrdina PD, Foy B, Summer RJ (1990b) 2D Imaging of serotonin uptake sites in brain with 3H-paroxetine: comparisom with 3H-imipramine. In: Leonard B, Spenser P (eds) Antidepressant: thirty years on. Portland Press LTD, pp 54–59

  • Langer SZ, Moret C, Raisman R, Dubocovich ML, Briley MS (1980) High-affinity 3H-imipramine binding in rat hippothalamus: association with uptake of serotonin but not of norepinephrine. Science 210: 1133–1135

    PubMed  Google Scholar 

  • Langer SZ, Javoy-Agid F, Raisman R, Briley M, Agid J (1981) Distribution of specific high affinity binding sites for 3H-imipramine in human brain. J Neurochem 37: 267–271

    PubMed  Google Scholar 

  • Langer SZ, Galzin AM, Poirier MF, Loo H, Sechter D, Zarifian E (1987) Association of 3H-imipramine and 3H-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression. J Recept Res 7: 499–521

    PubMed  Google Scholar 

  • Marcusson J, Fowler CJ, Hall H, Ross SB, Winblad B (1985) “Specific” binding of 3H-imipramine to protease-sensitive and protease-resistent sites. J Neurochem 44: 705–711

    PubMed  Google Scholar 

  • Marcusson JO, Backstrom IT, Ross SB (1986) Single-site model of the neural 5 hydroxytryptamine uptake and imipramine binding site. Mol Pharmacol 30: 121–154

    PubMed  Google Scholar 

  • Marcusson J, Alafuzoff I, Backstrom IT, Ericson E, Gotffries CG, Winblad B (1987) 5 hydroxytryptamine-sensitive 3H-imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders. Brain Res 425: 137–145

    PubMed  Google Scholar 

  • Marcusson JO, Bergstrom M, Eriksson K, Ross SB (1988) Characterization of 3H-paroxetine binding in rat brain. J Neurochem 50: 1783–1790

    PubMed  Google Scholar 

  • Markwell MA, Haas SM, Bieber LL, Tolbert NE (1987) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 203–225

    Google Scholar 

  • Mellerup ET, Plenge P (1986) High affinity binding of 3H-paroxetine and 3H-imipramine to rat neural membranes. Psychopharmacology 89: 436–439

    PubMed  Google Scholar 

  • Moret C, Briley M (1991) Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotoninergic innervation in the rat. Psychiatry Res 38: 97–104

    PubMed  Google Scholar 

  • Palkovits M, Raisman R, Briley M, Langer SZ (1981) Regional distribution of 3H-imipramine binding in rat brain. Brain Res 210: 493–498

    PubMed  Google Scholar 

  • Paul SM, Rehavi M, Rice KC, Ittah Y, Skolnick P (1981) Does high affinity 3H-imipramine binding label serotonin reuptake sites in brain and platelets? Life Sci 28: 2753–2760

    PubMed  Google Scholar 

  • Plenge P, Mellerup ET, Laursen H (1990) Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine 3H citalopram and 3H-imipramine. Prog Neuropsychopharmacol 14: 61–72

    Google Scholar 

  • Plenge P, Mellerup ET, Laursen H (1991) Affinity modulation of 3H-imipramine, 3H-paroxetine and 3H-citalopram binding to the 5HT transporter from brain and platelets. Eur J Pharmacol 206: 243–250

    PubMed  Google Scholar 

  • Raisman R, Briley MS, Langer SZ (1979) High affinity 3H-imipramine binding in rat cerebral cortex. Eur J Pharmacol 58: 347–348

    PubMed  Google Scholar 

  • Raisman R, Sechter D, Briley MS, Zarifian E, Langer SZ (1981) High affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers. Psychopharmacology 77: 332–335

    Google Scholar 

  • Rosel P, Vallejo J, Oros M, et al (1995) Changes in platelet 3H-imipramine binding: influences of protein concentration of varying proportions of cytosol or intact platelets and displacing agents used. Biol Psychiatry 38/7: 464–470

    PubMed  Google Scholar 

  • Rosel P, Vallejo J, Oros M, et al (1996) Seasonal variability in blood platelet 3H-imipramine binding in healthy controls: age and gender effects. Biol Psichiatry in press

  • Severson JA, Marcusson JO, Osterburg HH, Finch CE, Winblad B (1985) Elevated density of 3H-imipramine binding in aged human brain. J Neurochem 45: 1382–1389

    PubMed  Google Scholar 

  • Sette M, Ruberg M, Raisman R, Scattom B, Zivkovic B, Agid Y, Langer SZ (1983) 3H-imipramine binding in subcellular fractions of rat cerebral cortex after chemical lesion of serotoninergic neurons. Eur J Pharmacol 95: 41–51

    PubMed  Google Scholar 

  • Suranyi-Cadotte B, Quirion R, McQuade P, et al (1984) Platelet 3H-imipramine binding: a state-dependent marker in depression. Neurosychopharmacol 8: 737–741

    Google Scholar 

Download references

Author information

Author notes

  1. P. Rosel

    Present address: Hormone Unit, Hospital Princeps d'Espanya, Barcelona, Spain

Authors and Affiliations

  1. Hormone Unit, Hospital Princeps d'Espanya, Barcelona, Spain

    M. Oros, T. Cortadellas, B. Arranz & M. A. Navarro

  2. Department of Psychiatry, Hospital Princeps d'Espanya, Barcelona, Spain

    J. M. Menchon, J. Vallejo & P. Alvarez

  3. Department of Psychiatry, IMIM, Barcelona, Spain

    B. Arranz

Authors
  1. P. Rosel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. M. Menchon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Oros
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Vallejo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Cortadellas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Arranz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Alvarez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. A. Navarro
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The authors wish to thank P. Alastruey and E. Arnaiz from the technical staff of the Hormone Unit for their expert assistance.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosel, P., Menchon, J.M., Oros, M. et al. Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain. J. Neural Transmission 104, 89–96 (1997). https://doi.org/10.1007/BF01271297

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01271297

Keywords

Search

Navigation